menu search

MVMDF / Mountain Valley MD highlights shift to commercially focused biotech with revenue-generating activities in business update

Mountain Valley MD highlights shift to commercially focused biotech with revenue-generating activities in business update
Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) said it has shifted focus to the commercialization strategy for those of its projects and technologies that it believes will best provide viable revenue streams for long-term company health and shareholder value. In a business update, the company told investors it was working toward commercial advancement in three primary lines of business: novel innovations that improve the administration and efficacy of nutraceutical health and wellness products; agricultural plant signalling technology that organically drives increases in crop yields and supports and reduction of fertilizer usage; and the application of solubilized drugs to positively impact husbandry animal health. Read More
Posted: Nov 29 2022, 11:49
Author Name: Proactive Investors
Views: 112542

MVMDF News  

Mountain Valley MD appoints Lucie Letellier as new CFO

By Proactive Investors
September 8, 2023

Mountain Valley MD appoints Lucie Letellier as new CFO

Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) announced it has appointed Lucie Letellier to replace Aaron Triplett as its chief financial of more_horizontal

Mountain Valley MD highlights progress in core business lines

By Proactive Investors
August 11, 2023

Mountain Valley MD highlights progress in core business lines

Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) said it continues to progress in commercializing its three core lines of business. “The MVMD more_horizontal

Mountain Valley MD licenses modified ivermectin product to treat fish and wildlife for parasites in Bangladesh

By Proactive Investors
May 8, 2023

Mountain Valley MD licenses modified ivermectin product to treat fish and wildlife for parasites in Bangladesh

Mountain Valley MD has agreed to a license its parasitic infection treatment Soluvec 1% to a private Ontario company that intends to use it for animal more_horizontal

Mountain Valley MD highlights shift to commercially focused biotech with revenue-generating activities in business update

By Proactive Investors
November 29, 2022

Mountain Valley MD highlights shift to commercially focused biotech with revenue-generating activities in business update

Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) said it has shifted focus to the commercialization strategy for those of its projects and tech more_horizontal


Search within

Pages Search Results: